Thursday, January 23rd, 2025 at 4:15pm Eastern Time
WINNIPEG, Manitoba, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; KNBIF) (”Kane”)
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc.
Total Revenue: $1,283,000 for Q3 2024, compared to $27,000 for Q3 2023.Product Sales: $598,000 for Q3 2024, compared to $4,000 for Q3 2023.Product Services Rev
Dec 03, 2024 / 09:30PM GMTOperator Good afternoon and thank you for standing by. Welcome to Kane Biotech's third quarter, 2024 earnings conference call. (Operat
Company Records First Commercial Sale of revyveâ„¢ Wound GelWINNIPEG, Manitoba, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF)
Company Records First Commercial Sale of revyveâ„¢ Wound Gel
WINNIPEG, Manitoba, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; KNBIF) (”
BioStem Technologies Signs Letter of Intent to Acquire Exclusive US Distribution Rights for revyveâ„¢ from ProgenaCare Global
WINNIPEG, Manitoba, Nov. 27, 20
Animalcare Group PLC announced on Thursday its decision to sell equity in its joint venture, STEM Animal Health Inc, to Dechra Pharmaceuticals Ltd.
The York, UK-based animal health business reached...
The demand for advanced wound dressing is increasing owing to technological advancements, the increasing number of surgical procedures, and the rising...
North America leads the global hydrogel dressing market with an anticipated 8.7% CAGR, driven by advanced healthcare systems, increased adoption of wound...
/PRNewswire/ -- The "Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key...